Statin use and risk of prostate cancer: Results from the Southern Community Cohort Study

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0045|75|13|1384-1393

ISSN： 0270-4137

Source： THE PROSTATE, Vol.75, Iss.13, 2015-09, pp. : 1384-1393

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Statin use and risk of pancreatic cancer: Results from a large, clinic‐based case‐control study

By  

CANCER, Vol. 121, Iss. 8, 2015-04 ,pp. : 1287-1294

John Wiley & Sons Inc

Access to resources Recommend Favorite

ABO blood group alleles and prostate cancer risk: Results from the breast and prostate cancer cohort consortium (BPC3)

By  

THE PROSTATE, Vol. 270-4137, Iss. 15, 2015-11 ,pp. : 1677-1681

John Wiley & Sons Inc

Access to resources Recommend Favorite

ABO blood group alleles and prostate cancer risk: Results from the breast and prostate cancer cohort consortium (BPC3)

By  

THE PROSTATE, Vol. 75, Iss. 15, 2015-11 ,pp. : 1677-1681

John Wiley & Sons Inc

Access to resources Recommend Favorite

Metabolic syndrome‐like components and prostate cancer risk: results from the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) study

By  

BJU INTERNATIONAL, Vol. 115, Iss. 5, 2015-05 ,pp. : 736-743

John Wiley & Sons Inc

Access to resources Recommend Favorite

Baseline prostate inflammation is associated with a reduced risk of prostate cancer in men undergoing repeat prostate biopsy: Results from the REDUCE study

By  

CANCER, Vol. 120, Iss. 2, 2014-01 ,pp. : 190-196

John Wiley & Sons Inc

Access to resources Recommend Favorite